University of Ioannina
Μελέτη του ρόλου των παραγόντων πήξης Xa και θρομβίνης στην αθηροθρόμβωση
Abstract
dc:descriptionEndothelial cells play a crucial role in atherosclerosis. Endothelial dysfunction contributes to the first stages of plaque formation through the recruitment of leukocytes to the endothelium. The rupture of the atherosclerotic plaque leads to platelet activation and thrombosis. Endothelial progenitor cells (EPCs) are pluripotent cells that differentiate into mature endothelial cells, contributing to endothelial regeneration. It has been proved that circulating CD34+ cells differentiate into EPCs after their interaction with platelets and that this interaction leads to further maturation into endothelial cells. Coagulation factors Xa (FXa) and thrombin, apart from their haemostatic role, exhibit also non-haemostatic cellular effects that are mediated through protease-activated receptors (PARs), which are found on various cell types, such as platelets and endothelial cells. The aim of the present study was to investigate the role of FXa and thrombin in platelet activation and aggregation, as well as their role in EPC activation. For this purpose, the role of these factors in platelet activation and aggregation, as well as the effect of the direct oral anticoagulants rivaroxaban and dabigatran, which target FXa and thrombin respectively, was studied using PRP, washed platelets and whole blood. Additionally, the role of PAR-1 in FXa- or thrombin-induced platelet activation and aggregation was studied using the selective PAR-1 antagonist, vorapaxar. Platelet activation and aggregation were evaluated using light transmittance aggregometry, impendance aggregometry and flow cytometry. Moreover, the role of PAR-1 in the differentiation of CD34+ cells into EPCs, as well as on the formation of CD34+ cells/platelets conjugates, were aso studied using flow cytometry. Consequently, the role of FXa and thrombin in late-outgrowth endothelial cell activation (OECs) was investigated using the membrane expression of the adhesion molecule ICAM-1, as well as the expression of MCP-1, as activation markers. The role of rivaroxaban and dabigatran, as well as the role of PAR-1 on OEC activation by FXa and thrombin, were also evaluated. The present study proved that FXa and thrombin are potent platelet agonists and that FXa exhibits a delayed aggregatory effect. Platelet activation by these factors is mediated mainly via PAR-1. Furthermore, rivaroxaban and dabigatran inhibit FXa- and thrombin-induced platelet aggregation in a dose-dependent manner, without showing selectivity over one factor. PAR-1 also mediates the differentiation of CD34+ cells into EPCs, as well as the formation of CD34+ cells/platelets conjugates. The present study also proved that FXa and thrombin induce the expression of ICAM-1 and MCP-1 from OECs, mainly though PAR-1 activation. Vorapaxar does not fully inhibit thrombin-induced ICAM-1 expression and MCP-1 secretion from OECs, whereas it fully inhibits the above expression from HUVECs, a result that suggests the contribution of PAR-4 in this expression from OECs. Rivaroxaban and dabigatran inhibit in a dose-dependent manner FXa- and thrombin-induced ICAM-1 expression and MCP-1 secretion, respectively. An interesting finding that was observed for the first time was the enhancement of the thrombin-induced ICAM-1 expression and MCP-1 secretion by rivaroxaban. This enchancement effect was inhibited by vorapaxar, showing the participation of PAR-1 in this action. In conclusion, platelet and endothelial cell activation by FXa and thrombin could contribute in atherothrombosis. In addition, their action on OECs could be beneficial on endothelial regeneration. Even though in the present study various cellular effects of FXa and thrombin were investigated, more studies are required in order to fully decipher their role, as well as the contribution of their respective drugs, in atherothrombosis, endothelial regeneration and angiogenesis.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Papadaki, Styliani
- Παπαδάκη, Στυλιανή
Subjects
dc:subject × 18Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/46967